Effectiveness of BenZalkonium Chloride Gel as Vaginal Contraceptive: a Multicentric Randomized Controlled Trial
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
A multicentric clinical trial in three Chinese Maternal and Child Hospitals was conducted to
evaluate the efficacy, safety and acceptability of newly-developed vaginal contraceptive gel,
the optimized benzalkonium chloride (BZK) gel containing 18mg BZK, with comparison to a
currently marketed (in China)contraceptive gel LELEMI® containing 50mg Nonoxynol-9 (N-9).
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai Institute of Planned Parenthood Research
Collaborators:
Chang Jiang Bio-pharmaceutical Co., Ltd. Fudan University International Peace Maternity and Child Health Hospital Shanghai Municipal Commission of Health and Family Planning Shanghai Municipal Commission of Population and Family Planning Shanghai No. 1 Maternity and Child Care Center